ArticlePloS one2013

The KCNH2 genetic polymorphism (1956, C>T) is a novel biomarker that is associated with CCB and α,β-ADR blocker response in EH patients in China.

Fazhong He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.